These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26084349)

  • 21. Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis.
    Takahashi K; Kurihara Y; Suzuki Y; Goshima Y; Tanaka F; Takei K
    JAMA Neurol; 2015 Feb; 72(2):176-9. PubMed ID: 25437093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Features of intrathecal immunoglobulins in patients with multiple sclerosis.
    Di Pauli F; Gredler V; Kuenz B; Lutterotti A; Ehling R; Gneiss C; Schocke M; Deisenhammer F; Reindl M; Berger T
    J Neurol Sci; 2010 Jan; 288(1-2):147-50. PubMed ID: 19828154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
    Komori M; Matsuyama Y; Nirasawa T; Thiele H; Becker M; Alexandrov T; Saida T; Tanaka M; Matsuo H; Tomimoto H; Takahashi R; Tashiro K; Ikegawa M; Kondo T
    Ann Neurol; 2012 May; 71(5):614-23. PubMed ID: 22522477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.
    Dong-Si T; Weber J; Liu YB; Buhmann C; Bauer H; Bendl C; Schnitzler P; Grond-Ginsbach C; Grau AJ
    J Neurol; 2004 May; 251(5):542-7. PubMed ID: 15164186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum amyloid A level is increased in neuromyelitis optica and atypical multiple sclerosis with smaller T2 lesion volume in brain MRI.
    Yokote H; Yagi Y; Watanabe Y; Amino T; Kamata T; Mizusawa H
    J Neuroimmunol; 2013 Jun; 259(1-2):92-5. PubMed ID: 23566403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
    Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
    Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis.
    Alsahebfosoul F; Zavaran Hosseini A; Salehi R; Etemadifar M; Esmaeil N; Jamshidian A
    Iran J Allergy Asthma Immunol; 2015 Jun; 14(3):298-305. PubMed ID: 26546899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, magnetic resonance imaging, cerebrospinal fluid and electrophysiological characteristics of the earliest multiple sclerosis.
    Rot U; Ledinek AH; Jazbec SS
    Clin Neurol Neurosurg; 2008 Mar; 110(3):233-8. PubMed ID: 18093725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
    Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
    J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics.
    Zamboni P; Menegatti E; Weinstock-Guttman B; Schirda C; Cox JL; Malagoni AM; Hojanacki D; Kennedy C; Carl E; Dwyer MG; Bergsland N; Galeotti R; Hussein S; Bartolomei I; Salvi F; Zivadinov R
    Funct Neurol; 2009; 24(3):133-8. PubMed ID: 20018140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.
    Burman J; Svenningsson A
    J Neuroimmunol; 2016 Mar; 292():40-4. PubMed ID: 26943957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GFAP in early multiple sclerosis: A biomarker for inflammation.
    Kassubek R; Gorges M; Schocke M; Hagenston VAM; Huss A; Ludolph AC; Kassubek J; Tumani H
    Neurosci Lett; 2017 Sep; 657():166-170. PubMed ID: 28802830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study.
    Saida T; Tashiro K; Itoyama Y; Sato T; Ohashi Y; Zhao Z;
    Neurology; 2005 Feb; 64(4):621-30. PubMed ID: 15728282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of the HLADR13 allele among Mexican Mestizos suggests a protective factor against relapsing-remitting multiple sclerosis (RRMS).
    Flores J; Granados J; Alonso E; Rito Y; Ortega-Hernández E; Mena-Hernández L; Corona T
    Clin Neurol Neurosurg; 2015 Nov; 138():184-7. PubMed ID: 26367070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis.
    Orefice N; Carotenuto A; Mangone G; Bues B; Rehm R; Cerillo I; Saccà F; Calignano A; Orefice G
    J Steroid Biochem Mol Biol; 2016 May; 159():1-7. PubMed ID: 26892094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
    Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
    Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early diffuse demyelinating lesion in the cervical spinal cord predicts a worse prognosis in relapsing-remitting multiple sclerosis.
    Coret F; Bosca I; Landete L; Magraner MJ; Navarré A; León JL; Casanova B
    Mult Scler; 2010 Aug; 16(8):935-41. PubMed ID: 20573640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis.
    Castellazzi M; Tamborino C; Cani A; Negri E; Baldi E; Seraceni S; Tola MR; Granieri E; Contini C; Fainardi E
    Mult Scler; 2010 Jul; 16(7):883-7. PubMed ID: 20483883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis.
    Fainardi E; Rizzo R; Castellazzi M; Stignani M; Granieri E; Baricordi OR
    Hum Immunol; 2009 Dec; 70(12):981-7. PubMed ID: 19651179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.